Carlsmed, Inc. Fair Value Adjustment of Warrants
Carlsmed, Inc. (CARL) reported Fair Value Adjustment of Warrants of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-05
- Carlsmed, Inc. fair value adjustment of warrants for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Carlsmed, Inc. fair value adjustment of warrants for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Carlsmed, Inc. fair value adjustment of warrants for the quarter ending 2025-12-31 was -$7.00K, a 112.73% decline year-over-year.
- Carlsmed, Inc. fair value adjustment of warrants for the quarter ending 2025-09-30 was $65.00K, a 132.14% increase year-over-year.
- Carlsmed, Inc. fair value adjustment of warrants for fiscal 2025 was $328.00K, a 127.78% increase from fiscal 2024.
- Carlsmed, Inc. fair value adjustment of warrants for fiscal 2024 was $144.00K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | -$7.00K derived: sum of 3 quarters · filed 2026-08-05 | $58.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-05 | -$7.00K derived: sum of 2 quarters · filed 2026-05-05 | $58.00K derived: sum of 3 quarters · filed 2026-05-05 | $295.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $58.00K derived: sum of 2 quarters · filed 2026-02-25 | $295.00K derived: sum of 3 quarters · filed 2026-08-05 | $328.00K 10-K · filed 2026-02-25 |
| 2025-09-30 | $65.00K 10-Q · filed 2025-11-06 | $302.00K derived: sum of 2 quarters · filed 2026-08-05 | $335.00K 10-Q · filed 2025-11-06 | $390.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $237.00K 10-Q · filed 2026-08-05 | $270.00K 10-Q · filed 2026-08-05 | $325.00K derived: sum of 3 quarters · filed 2026-08-05 | $353.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $33.00K 10-Q · filed 2026-05-05 | $88.00K derived: sum of 2 quarters · filed 2026-05-05 | $116.00K derived: sum of 3 quarters · filed 2026-05-05 | $177.00K derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $83.00K derived: sum of 2 quarters · filed 2026-02-25 | $144.00K derived: sum of 3 quarters · filed 2026-02-25 | $144.00K 10-K · filed 2026-02-25 |
| 2024-09-30 | $28.00K 10-Q · filed 2025-11-06 | $89.00K derived: sum of 2 quarters · filed 2025-11-06 | $89.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $61.00K 10-Q · filed 2025-08-28 | $61.00K 10-Q · filed 2025-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |